2013-03-04 08:23:13 -

Royal DSM, the global Life Sciences and Materials Sciences company, announced
today that it has completed the sale of its participation in DEXPlastomers
V.o.F, a 50/50 Joint Venture of DSM with an affiliate of ExxonMobil Chemical, to
Borealis. DSM also sold its LldPE Compact Solution Technology to Borealis. The
transaction was announced in November 2012.

Established in 1996, DEXPlastomers is a 50/50 joint venture between DSM and
Exxon Chemical Holland Ventures B.V., producing C8 plastomers and linear low
density polyethylene. In the scope of the transaction are approximately 100
employees who have transferred to the new owner upon closing. DSM's LldPE
Compact Solution Technology was first developed in the 1960's to produce
polyethylenes in a certain density range and is instrumental to the operations
of DEXPlastomers.

For DSM, a sale of DEXPlastomers   is in line with its long-term focus of being a
Life Sciences and Materials Sciences company, active in health, nutrition and
materials. DSM's 50% participation in DEXPlastomers was reported under Corporate
Activities in DSM's accounts.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around €9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.

Or find us on:




For more information:
 DSM Corporate Communications     DSM Investor Relations
 Herman Betten                    Dave Huizing
 tel. +31 (0) 45 5782017          tel. +31 (0) 45 5782864
 fax +31 (0) 45 5740680           fax +31 (0) 10 4590275
 e-mail media.relations@dsm.com   e-mail investor.relations@dsm.com


Press release-pdf: 
 hugin.info/130663/R/1682603/550446.pdf



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: DSM N.V.  via Thomson Reuters ONE
[HUG#1682603]